SEARCH

SEARCH BY CITATION

References

  • Barkus E, Morrison PD, Vuletic D, Dickson JC, Ell PJ, Pilowsky LS et al. (2011). Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study. J Psychopharmacol 25: 14621468.
  • Bechara A (2005). Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci 8: 14581463.
  • Bossong MG, Berckel BNM, Boellaard R, Zuurman L, Schuit RC, Windhorst AD et al. (2009). Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 34: 759766.
  • Breiter HC, Gollub RL, Weisskoff RM, Kennedy DN, Makris N, Berke JD et al. (1997). Acute effects of cocaine on human brain activity and emotion. Neuron 19: 591611.
  • Burns M (1991). Pharmacology of cocaine and its relationship to behavior impairment. In The effects of drugs on human performance and behavior: drugs and driving/drugs in the workplace.
  • Burns M (1992). Cocaine effects on performance. In International Conference on Alcohol, Drugs and Traffic Safety, pp 613619.
  • Childers SR, Breivogel CS (1998). Cannabis and endogenous cannabinoid systems. Drug Alcohol Depend 51: 173187.
  • Crean RD, Crane NA, Mason BJ (2012). An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med 5: 18.
  • EMCDDA (2009). Polydrug use: patterns and responses (Luxembourg).
  • EMCDDA (2011). Annual drug update: 2011 in review.
  • Faure A, Richard JM, Berridge KC (2010). Desire and dread from the nucleus accumbens: cortical glutamate and subcortical GABA differentially generate motivation and hedonic impact in the rat. PLoS ONE 5: e11223.
  • Fillmore MT, Rush CR, Hays L (2002). Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend 67: 157167.
  • Fillmore MT, Rush CR, Hays L (2005). Cocaine improves inhibitory control in a human model of response conflict. Exp Clin Psychopharmacol 13: 327336.
  • Fillmore MT, Rush CR, Hays L (2006). Acute effects of cocaine in two models of inhibitory control: implications of non-linear dose effects. Addiction 101: 13231332.
  • Garavan H, Kaufman JN, Hester R (2008). Acute effects of cocaine on the neurobiology of cognitive control. Philos Trans R Soc Lond B Biol Sci 363: 32673276.
  • Gonzalez R (2007). Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychol Rev 17: 347361.
  • Hart CL, Ilan AB, Gevins A, Gunderson EW, Role K, Colley J et al. (2010). Neurophysiological and cognitive effects of smoked marijuana in frequent users. Pharmacol Biochem Behav 96: 333341.
  • Hazekamp A, Ruhaak R, Zuurman L, Gerven JVA, Verpoorte ROB (2006). Evaluation of a vaporizing device (Volcano 1) for the pulmonary administration of tetrahydrocannabinol. J Pharm Sci 95: 13081317.
  • Jex HR, McDonnell JD, Phatak AV (1966). A ‘critical’ tracking task for manual control research. IEEE 7: 138145.
  • Kalivas PW, Volkow ND (2005). The neural basis of addiction? A pathology of motivation and choice. Am J Psychiatry 162: 14031413.
  • Kauert GF, Iwersen-Bergmann S, Toennes SW (2006). Assay of delta9-tetrahydrocannabinol (THC) in oral fluid-evaluation of the OraSure oral specimen collection device. J Anal Toxicol 30: 274277.
  • Kuepper R, Ceccarini J, Lataster J, van Os J, van Kroonenburgh M, van Gerven JM et al. (2013). Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study. PLoS One 8: e70378.
  • Logan GD, Cowan WB (1984). On the ability to inhibit thought and action: a theory of an act of control. Psychol Rev 91: 295327.
  • McDonald J, Schleifer L, Richards JB, Wit H (2003). Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 28: 13561365.
  • Messer SB (1976). Reflection-impulsivity: a review. Psychol Bull 83: 10261052.
  • Metrik J, Kahler CW, Reynolds B, McGeary JE, Monti PM, Haney M et al. (2012). Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology (Berl) 223: 489499.
  • Panlilio LV, Solinas M, Matthews S, Goldberg SR (2007). Previous exposure to THC alters the reinforcing efficacy and anxiety-related effects of cocaine in rats. Neuropsychopharmacology 32: 646657.
  • Perales JC, Verdejo-Garcia A, Moya M, Lozano O, Perez-Garcia M (2009). Bright and dark sides of impulsivity: performance of women with high and low trait impulsivity on neuropsychological tasks. J Clin Exp Neuropsychol 31: 927944.
  • Perkonigg A, Lieb R, Höfler M, Schuster P, Sonntag H, Wittchen HU (1999). Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents. Addiction 94: 16631678.
  • Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL (2004). Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol Psychiatry 56: 8694.
  • Ramaekers JG, Kuypers KPC (2006). Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol. Neuropsychopharmacology 31: 10481055.
  • Ramaekers JG, Kauert G, Ruitenbeek P, Theunissen EL, Schneider E, Moeller MR (2006a). High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 31: 22962303.
  • Ramaekers JG, Moeller MR, Ruitenbeek P, Theunissen EL, Schneider E, Kauert G (2006b). Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend 85: 114122.
  • Ramaekers JG, Kauert G, Theunissen EL, Toennes SW, Moeller MR (2009). Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J Psychopharmacol 23: 266277.
  • Ramaekers JG, Theunissen EL, Brouwer M, Toennes SW, Moeller MR, Kauert G (2011). Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology (Berl) 214: 391401.
  • Shallice T (1982). Specific impairments of planning. Philos Trans R Soc Lond 298: 199209.
  • Solowij N (1998). Cannabis and Cognitive Functioning. Cambridge University Press: Cambridge.
  • Toennes SW, Steinmeyer S, Maurer H-J, Moeller MR, Kauert GF (2005). Screening for drugs of abuse in oral fluid – correlation of analysis results with serum in forensic cases. J Anal Toxicol 29: 2227.
  • Toennes SW, Ramaekers JG, Theunissen EL, Moeller MR, Kauert GF (2008). Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint. J Anal Toxicol 32: 470477.
  • Toennes SW, Schneider K, Kauert GF, Wunder C, Moeller MR, Theunissen EL et al. (2011). Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users. Anal Bioanal Chem 400: 145152.
  • Urban NBL, Slifstein M, Thompson JL, Xu X, Girgis RR, Raheja S et al. (2012). Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study. Biol Psychiatry 71: 677683.
  • Van Dyke CV, Barash P, Jatlow P, Byck R (1976). Cocaine: plasma concentrations after intranasal application in man. Science 191: 859861.
  • van Wel JHP, Kuypers KPC, Theunissen EL, Bosker WM, Bakker K, Ramaekers JG (2012). Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors. PLoS ONE 7: e40187.
  • Wilkinson P, Dyke CV, Jatlow P, Barash P, Byck R (1980). Intranasal and oral cocaine kinetics. Clin Pharmacol Ther 27: 386394.
  • Zanettini C, Panlilio LV, Alicki M, Goldberg SR, Haller J, Yasar S (2011). Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front Behav Neurosci 5: 121.